InfuSystems HoldingsINFU +1.40%87 PS Ratio is 1.49 as of Jul. 05, 2026, which is 4% above its 10-year median of 1.43. GuruFocus rates INFU with a GF Score™ of 87/100 and a GF Value™ of $9.44 (Fairly Valued). The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, InfuSystems Holdings ranks better than 71.06% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, InfuSystems Holdings's share price is $10.16.
InfuSystems Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $6.80. Hence, InfuSystems Holdings's PS Ratio for today is 1.49.
Warning Sign:
InfuSystems Holdings Inc stock PS Ratio (=1.49) is close to 2-year high of 1.65.
The historical rank and industry rank for InfuSystems Holdings's PS Ratio or its related term are showing as below:
INFU'
s PS Ratio Range Over the Past 10 Years
Min: 0.43 Med: 1.43 Max: 4.92
Current: 1.49
During the past 13 years, InfuSystems Holdings's highest PS Ratio was 4.92. The lowest was 0.43. And the median was 1.43.
INFU's PS Ratio is ranked better than 71.06% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 2.94
vs INFU: 1.49
InfuSystems Holdings Inc has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of InfuSystems Holdings was 6.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 10.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 9.20% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 9.20% per year.
During the past 13 years, InfuSystems Holdings's highest 3-Year average Revenue per Share Growth Rate was 88.10% per year. The lowest was 0.50% per year. And the median was 9.20% per year.
Back to Basics: PS Ratio
InfuSystems Holdings (AMEX:INFU) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
InfuSystems Holdings PS Ratio Related Terms
InfuSystems Holdings PS Ratio Historical Data
* Premium members only.
The historical data trend for InfuSystems Holdings's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, InfuSystems Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InfuSystems Holdings PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's PS Ratio distribution charts can be found below:
* The bar in red indicates where InfuSystems Holdings's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
InfuSystems Holdings's Share Price of today is $10.16. InfuSystems Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.80.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
InfuSystems Holdings (INFU) has a PS Ratio of 1.49 as of Jul. 05, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on InfuSystems Holdings and its competitors. This is near median its historical median of 1.43. Over the past decade, InfuSystems Holdings' PS Ratio has ranged from 0.43 to 4.92. According to the industry distribution chart, InfuSystems Holdings ranks #233 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 28.9%.
Is InfuSystems Holdings' PS Ratio too high?
InfuSystems Holdings' current PS Ratio of 1.49 is near median its 10-year median of 1.43. Over the past 10 years, this metric has ranged from a low of 0.43 to a high of 4.92. The Medical Devices & Instruments industry median PS Ratio is 2.94. InfuSystems Holdings' value of 1.49 is 49.3% below this industry median. Based on the distribution chart, InfuSystems Holdings ranks #233 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, InfuSystems Holdings has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does InfuSystems Holdings' PS Ratio compare to QTRX and LUCD?
According to the Medical Devices & Instruments industry distribution chart, InfuSystems Holdings ranks #233 out of 805 companies for PS Ratio. This puts InfuSystems Holdings in the upper half of its industry. The industry median PS Ratio is 2.94. InfuSystems Holdings' value of 1.49 is 49.3% below this benchmark. Historically, InfuSystems Holdings' own PS Ratio has ranged from 0.43 to 4.92 over the past decade. While the company's 10-year median is 1.43 vs. the industry median of 2.94, InfuSystems Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InfuSystems Holdings's current PS Ratio of 1.49 is 49.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on InfuSystems Holdings and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InfuSystems Holdings's current PS Ratio is 1.49, which is near median its own 10-year median of 1.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InfuSystems Holdings stock overvalued right now?
Based on GuruFocus' analysis, InfuSystems Holdings (INFU) is currently considered Fairly Valued. The stock's GF Value™ is $9.44, compared to a current price of $10.16 — trading 7.6% above its estimated fair value. The current PS Ratio is 1.49, which is near median its 10-year median of 1.43 and 49.3% below the Medical Devices & Instruments industry median of 2.94. InfuSystems Holdings' overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For InfuSystems Holdings (INFU), the current PS Ratio is 1.49 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InfuSystems Holdings (INFU) Overvalued in 2026?
Based on GuruFocus' analysis, InfuSystems Holdings stock appears to be overvalued.
The current stock price of $10.16 is trading 7.6% above its estimated GF Value™ of $9.44.
GuruFocus considers InfuSystems Holdings to be Fairly Valued.
Key valuation signals for INFU:
PS Ratio: 1.49 (near median its 10-year median of 1.43)
GF Value™: $9.44 vs. price of $10.16 (7.6% above fair value)
Industry Position: 49.3% below the Medical Devices & Instruments median (#233 of 805)
No single metric tells the full story. See the INFU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.
87GF Score
Get the complete analysis for INFU
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INFU has been successfully added to your 
